RVMD: Mancini Anthony discloses a sale
By AlphaYouPublished Form 4
Mancini Anthony
Reporting filer
Mancini Anthony reported Sale in Revolution Medicines, Inc.: 1764 units of Common Stock, dated 2026-09-18. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 22, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Mancini Anthony | 2026-09-18 | S | Sale | 1764 | 196.94 | 40,352 | 4 days | Filed terms
|
Common Stock
- Owner
- Mancini Anthony
- Date
- 2026-09-18
- Code
- S
- Action
- Sale
- Quantity
- 1764
- Price
- 196.94
- Following holdings
- 40,352
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-18
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 1764
- transaction Price Per Share: 196.94
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 40352
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Mancini Anthony: See Remarks.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.